MoneyWorks4Me

Ajanta Pharma submits disclosures

29 Nov 2021 Evaluate

Ajanta Pharma has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 29, 2021 for Aayush M Agrawal, Trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..